Despite the widely accepted recognition of the importance of tumor microenvironment, comprehensive investigation into specific aspects such as immune-related signaling in FOXA1 mutant prostate cancer has remained largely unexplored. This evidence concerns the gene FOXA1 and prostate carcinoma.